Parker Institute for Cancer Immunotherapy has named Karen E. Knudsen, MBA, PhD, as its new CEO, according to a press ...
SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA PhD as its new chief executive officer.
Karen Knudsen, PhD, has been appointed CEO of San Francisco-based Parker Institute for Cancer Immunotherapy. Dr. Knudsen previously served as CEO for both the American Cancer Society and ACS Cancer ...
In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, Gather Health’s new primary care model, Airna’s $155 million deal, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results